Case ID: M26-161L

Published: 2026-08-21 12:16:35

Last Updated: 1787314595


Inventor(s)

Rizal Hariadi
Ranjan Sasmal

Technology categories

Biological NanotechnologyChemical/Biological SensorsDiagnostic Assays/DevicesLife Science (All LS Techs)

Licensing Contacts

Pragnesh Mistry
Licensing and Business Development Associate – Life Sciences
[email protected]

HALOS: Synthetic Transmembrane Signaling with Amphiphilic DNA Nanostructures

Invention Description
High false-positive rates limit the diagnostic accuracy of isothermal nucleic acid amplification methods and may require additional validation. Hybridization Chain Reactions (HCR) enable enzyme-free signal amplification using metastable DNA hairpins that polymerize when triggered by an initiator. However, spontaneous hairpin opening, partial initiator fragments, and non-specific activation cause significant background leakage. Current solutions only marginally reduce this background and often lower amplification efficiency.
 
Researchers at Arizona State University have developed HALOS (Hybridization Across Lipid for Optical Signaling), a synthetic DNA-based transmembrane signaling platform that mimics the function of G protein-coupled receptors (GPCRs). Using amphiphilic DNA hairpin nanostructures with cholesterol anchors and toehold-mediated strand displacement, HALOS non-invasively detects intracellular nucleic acid targets and enable signal transduction across lipid bilayers. Use of a split-initiator design divides the amplification initiator into two components requiring spatial proximity for function, creating a molecular logic AND gate that significantly reduces false positive rates while maintaining a 5-fold amplification in synthetic vesicles and 2.6-5.4-fold in live mammalian cells. This system enables lysis-free diagnostics and intracellular RNA sensing through amplified, enzyme-free hybridization chain reactions.
 
These innovative DNA nanostructures enable programmable signal transduction and amplification across lipid membranes, enhancing biological detection and diagnostics.
 
Potential Applications
  • Intracellular RNA and DNA sensing for diagnostics
  • Synthetic biology tools for cellular signaling/control & drug discovery
  • Targeted therapeutic activation and smart drug delivery systems
  • Platforms for programmable biomolecular engineering and nanoscale devices
  • Cellular imaging and live cell monitoring in research and clinical settings
  • Development of biosensors for signaling pathway analysis
Benefits and Advantages
  • Programmable and customizable DNA structures for targeted signaling
  • Significant signal amplification with HALOS technique
  • Potential for multiplexed detection and use in complex biological environments
  • Non-invasive and compatible with live cell diagnostics
  • High sensitivity with nanomolar detection limits
  • High specificity and stability in diverse biological environments
  • Versatile platform adaptable to various medical and research applications
For more information about this opportunity, please see